EPTIBRA trademark by Pfizer Inc. (86221048) | Applied Marks - Trademark, Domain Name and Social Media Protection for Brands - /\\\ Applied Marks
number Pfizer Inc. EPTIBRA 86221048 number Pfizer Inc. EPTIBRA 86221048

Trademark 'EPTIBRA' owned by 'Pfizer Inc.'

This page for the EPTIBRA brand registered to Pfizer Inc..

On 2014-03-14 an application for registration of a trademark was filed with IP Australia by Pfizer Inc.. At the time of application IP Australia assigned number 86221048. As at the last database update (on 2017-08-12) the status of this trademark application was FIFTH EXTENSION - GRANTED.

If you would like further information about products associated the EPTIBRA mark or goods and/or services supplied by Pfizer Inc., please contact them directly.
2014-03-14
US
  • 5
    Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
    pharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, hematologic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurological, oncological, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of erectile dysfunction, sexual dysfunction and pain; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations, smoking cessation preparations; vaccines for human use
734
FIFTH EXTENSION - GRANTED
2017-08-11
2017-08-12
health her women heart care salud living advancing chas york cv mission bridge program rewards community advocacy connection cuentos starting
First 1 Last  1 of 1
NEED HELP? Chat with us online

Copyright 2008 - 2017 Applied Marks Pty Ltd (ACN 134 698 249). All rights reserved. Terms of Service, Privacy Policy and Acceptable Use Policy.